Point72 Hong Kong’s Pulse Biosciences PLSE Stock Holding History

Point72 Hong Kong’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-273	Closed	-$1K	–	2306
2022 Q1	$1K	Buy	+273	New	+$2.23K	﹤0.01%	1757

Other funds holding PLSE

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GAM

Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Point72 Hong Kong's PLSE Position: Q2 2022 in Review

Point72 Hong Kong sold out of Pulse Biosciences (PLSE) in Q2 2022, closing a stake of 273 shares — an estimated $1K sold.

Point72 Hong Kong first reported a position in PLSE in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 44 funds tracked by Wall St. Rank hold PLSE as of Q2 2022.

Point72 Hong Kong reported no remaining Pulse Biosciences position as of Q2 2022 after selling out during the quarter.
Point72 Hong Kong sold 273 Pulse Biosciences shares in Q2 2022, an estimated $1K.
Point72 Hong Kong first reported a position in Pulse Biosciences in Q1 2022 and held it in 1 quarter.
Point72 Hong Kong's Pulse Biosciences position peaked at $1K in Q1 2022.
44 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.